From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
November 14, 2018
Philadelphia, PA, November 14, 2018 – IntegriChain, a leading life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence, today announced that Solutions Principal Shivani Patel will conduct a workshop on “Retail Inventory and Pipeline Accruals” at the CBI GTN 2018 Conference. The GTN 2018 Conference delivers two days of sessions and workshops on strategic forecasting, accounting estimates, analytics, and financial reporting for life science companies, beginning November 15 at the Hilton Philadelphia at Penn’s Landing. Patel’s workshop will be on Thursday, November 15, at 2:45 pm.
“GTN forecasting is critical to financial success for all life sciences manufactures — from those still pre-commercial to those hitting the top of the portfolio and revenue charts,” said Patel. “During this CBI GTN 2018 Workshop, we’ll review real-world tactics and a comprehensive model that combines product demand, downstream inventory, and government rebate estimates for accurately forecasting gross-to-net.”
About IntegriChain IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. Our ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 140 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA; the Access Management Operations center is in Ambler, PA; and the Patient Services Center is in Atlanta, GA. For more information, visit www.integrichain.com or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Register Now
Webinars & Resources
See List
